2p3g
From Proteopedia
Line 1: | Line 1: | ||
[[Image:2p3g.jpg|left|200px]] | [[Image:2p3g.jpg|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_2p3g", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | + | or leave the SCENE parameter empty for the default display. | |
- | | | + | --> |
- | | | + | {{STRUCTURE_2p3g| PDB=2p3g | SCENE= }} |
- | + | ||
- | + | ||
- | }} | + | |
'''Crystal structure of a pyrrolopyridine inhibitor bound to MAPKAP Kinase-2''' | '''Crystal structure of a pyrrolopyridine inhibitor bound to MAPKAP Kinase-2''' | ||
Line 28: | Line 25: | ||
[[Category: Caspers, N.]] | [[Category: Caspers, N.]] | ||
[[Category: Kurumbail, R G.]] | [[Category: Kurumbail, R G.]] | ||
- | [[Category: | + | [[Category: Atp-binding]] |
- | [[Category: | + | [[Category: Kinase domain]] |
- | [[Category: | + | [[Category: Map kinase]] |
- | [[Category: | + | [[Category: Mk-2]] |
- | [[Category: | + | [[Category: Mk2]] |
- | [[Category: | + | [[Category: Serine/threonine kinase]] |
- | [[Category: | + | [[Category: Transferase]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 12:16:04 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 09:16, 4 May 2008
Crystal structure of a pyrrolopyridine inhibitor bound to MAPKAP Kinase-2
Overview
A new class of potent kinase inhibitors selective for mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK-2) for the treatment of rheumatoid arthritis has been prepared and evaluated. These inhibitors have IC50 values as low as 10 nM against the target and have good selectivity profiles against a number of kinases including CDK2, ERK, JNK, and p38. These MK-2 inhibitors have been shown to suppress TNFalpha production in U397 cells and to be efficacious in an acute inflammation model. The structure-activity relationships of this series, the selectivity for MK-2 and their activity in both in vitro and in vivo models are discussed. The observed selectivity is discussed with the aid of an MK-2/inhibitor crystal structure.
About this Structure
2P3G is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)., Anderson DR, Meyers MJ, Vernier WF, Mahoney MW, Kurumbail RG, Caspers N, Poda GI, Schindler JF, Reitz DB, Mourey RJ, J Med Chem. 2007 May 31;50(11):2647-54. Epub 2007 May 5. PMID:17480064 Page seeded by OCA on Sun May 4 12:16:04 2008